KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth
Shimoda et al. present evidence that a small functional peptide derived from the KSHV transactivator could be used to target MYC in cancer. The authors find that the peptide attenuates MYC expression, reduces cell proliferation, and selectively kills cancer cells in tissue culture and a xenograft tu...
Enregistré dans:
Auteurs principaux: | Michiko Shimoda, Yuanzhi Lyu, Kang-Hsin Wang, Ashish Kumar, Hiroki Miura, Joshua F. Meckler, Ryan R. Davis, Chanikarn Chantarasrivong, Chie Izumiya, Clifford G. Tepper, Ken-ichi Nakajima, Joseph Tuscano, Gustavo Barisone, Yoshihiro Izumiya |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eaec3f23d40d4e7a83a5c5ddca22da0a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
KSHV episomes reveal dynamic chromatin loop formation with domain-specific gene regulation
par: Mel Campbell, et autres
Publié: (2018) -
Androgen receptor transactivates KSHV noncoding RNA PAN to promote lytic replication-mediated oncogenesis: A mechanism of sex disparity in KS.
par: Mingzhu Ding, et autres
Publié: (2021) -
Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
par: Chen Gam ze Letova, et autres
Publié: (2021) - Coactivity / Santalka
-
MYC-type transcription factors, MYC67 and MYC70, interact with ICE1 and negatively regulate cold tolerance in Arabidopsis
par: Masaru Ohta, et autres
Publié: (2018)